UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

Nature communications, 2021-01, Vol.12 (1), p.165-165, Article 165

2021

Volltextzugriff (PDF)

1222 Antigen-specific delivery of TCR and costimulatory signals by a protein scaffold selectively activates and markedly expands naïve MART-1-specific CD8+ T cells

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1348-A1349

2023

Volltextzugriff (PDF)

1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1289-A1290

2023

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by Lipopolysaccharide

Journal of Virology, 2008-08, Vol.82 (15), p.7591-7600

2008

Volltextzugriff (PDF)

295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A336-A338

2023

Volltextzugriff (PDF)

243 Efficient generation of CD8+ TSCM CD19 chimeric antigen receptor T-cells (CAR-T cells) by treatment with novel cytokine-based scaffolds

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A280-A282

2023

Volltextzugriff (PDF)

Inhibition of In Vivo HIV Infection in Humanized Mice by Gene Therapy of Human Hematopoietic Stem Cells with a Lentiviral Vector Encoding a Broadly Neutralizing Anti-HIV Antibody

Journal of Virology, 2010-07, Vol.84 (13), p.6645-6653

2010

Volltextzugriff (PDF)

Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

Nature communications, 2021-05, Vol.12 (1), p.2958-2958, Article 2958

2021

Volltextzugriff (PDF)

Methamphetamine inhibits antigen processing, presentation, and phagocytosis

PLoS pathogens, 2008-02, Vol.4 (2), p.e28-e28

2008

Volltextzugriff (PDF)

Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy

PloS one, 2013-05, Vol.8 (5), p.e63537-e63537

2013

Volltextzugriff (PDF)

Transition states of native and drug-resistant HIV-1 protease are the same

Proceedings of the National Academy of Sciences - PNAS, 2012-04, Vol.109 (17), p.6543-6548

2012

Volltextzugriff (PDF)

Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV

Molecular therapy. Methods & clinical development, 2020-12, Vol.19, p.78-88

2020

Volltextzugriff (PDF)

Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity

Journal of Virology, 2008-03, Vol.82 (6), p.3078-3089

2008

Volltextzugriff (PDF)

Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice

PloS one, 2009-12, Vol.4 (12), p.e8208-e8208

2009

Volltextzugriff (PDF)

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

PLoS medicine, 2006-11, Vol.3 (11), p.e427

2006

Volltextzugriff (PDF)

Summary of presentations at the NIH/NIAID New Humanized Rodent Models 2007 Workshop

AIDS research and therapy, 2008-01, Vol.5 (1), p.3-3

Goldstein, Harris

2008

Volltextzugriff (PDF)

Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission

Current opinion in HIV & AIDS, 2024-07, Vol.19 (4), p.169-178

2024

Volltextzugriff (PDF)

Increased In Vivo Activation of Microglia and Astrocytes in the Brains of Mice Transgenic for an Infectious R5 Human Immunodeficiency Virus Type 1 Provirus and for CD4-Specific Expression of Human Cyclin T1 in Response to Stimulation by Lipopolysaccharides

Journal of Virology, 2008-06, Vol.82 (11), p.5562-5572

2008

Volltextzugriff (PDF)

623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A374-A375

2020

Volltextzugriff (PDF)

Interventions during Early Infection: Opening a Window for an HIV Cure?

Viruses, 2024-10, Vol.16 (10), p.1588

2024

Volltextzugriff (PDF)

Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model

Science translational medicine, 2019-08, Vol.11 (504)

2019

Volltextzugriff (PDF)

CD4-Specific Transgenic Expression of Human Cyclin T1 Markedly Increases Human Immunodeficiency Virus Type 1 (HIV-1) Production by CD4+ T Lymphocytes and Myeloid Cells in Mice Transgenic for a Provirus Encoding a Monocyte-Tropic HIV-1 Isolate

Journal of Virology, 2006-02, Vol.80 (4), p.1850-1862

2006

Volltextzugriff (PDF)

A novel action of minocycline: Inhibition of human immunodeficiency virus type 1 infection in microglia

Journal of neurovirology, 2004-10, Vol.10 (5), p.284-292

2004

Volltextzugriff (PDF)

Conserved epigenetic hallmarks of T-cell age

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.148-148.07

2023

Volltextzugriff (PDF)

1 – 25 von 547

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(446)
Mit Volltextzugriff
(409)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(290)
Life Sciences & Biomedicine
(262)
Humans
(245)
Female
(129)
Male
(122)
Biological And Medical Sciences
(108)
Medical Sciences
(80)
Adult
(78)
Animals
(78)
Middle Aged
(78)
Aged
(59)
Immunology
(50)
Mice
(50)
Virology
(47)
Infectious Diseases
(40)
Fundamental And Applied Biological Sciences. Psychology
(39)
Social Sciences
(36)
Neurosciences & Neurology
(34)
Aids/hiv
(31)
Adolescent
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

1222 Antigen-specific delivery of TCR and costimulatory signals by a protein scaffold selectively activates and markedly expands naïve MART-1-specific CD8+ T cells

1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells

Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by Lipopolysaccharide

295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells

243 Efficient generation of CD8+ TSCM CD19 chimeric antigen receptor T-cells (CAR-T cells) by treatment with novel cytokine-based scaffolds

Inhibition of In Vivo HIV Infection in Humanized Mice by Gene Therapy of Human Hematopoietic Stem Cells with a Lentiviral Vector Encoding a Broadly Neutralizing Anti-HIV Antibody

Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

Methamphetamine inhibits antigen processing, presentation, and phagocytosis

In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells

Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy

Transition states of native and drug-resistant HIV-1 protease are the same

Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV

Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity

Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

Summary of presentations at the NIH/NIAID New Humanized Rodent Models 2007 Workshop

Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission

Increased In Vivo Activation of Microglia and Astrocytes in the Brains of Mice Transgenic for an Infectious R5 Human Immunodeficiency Virus Type 1 Provirus and for CD4-Specific Expression of Human Cyclin T1 in Response to Stimulation by Lipopolysaccharides

623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo

Interventions during Early Infection: Opening a Window for an HIV Cure?

Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model

CD4-Specific Transgenic Expression of Human Cyclin T1 Markedly Increases Human Immunodeficiency Virus Type 1 (HIV-1) Production by CD4+ T Lymphocytes and Myeloid Cells in Mice Transgenic for a Provirus Encoding a Monocyte-Tropic HIV-1 Isolate

A novel action of minocycline: Inhibition of human immunodeficiency virus type 1 infection in microglia

Conserved epigenetic hallmarks of T-cell age

Suchergebnisse filtern